Acute limb ischemia associated with COVID-19 in Basra province, Iraq | [Rawal Medical Journal • 2023]

Author(s):

1. Thamir Fozzie Muhmood: Department of Cardiovascular Surgery, Basrah Health Directorate, Iraq

2. Mohammed Sanaa Alshukoor: Department of Cardiovascular Surgery, Basrah Health Directorate, Iraq

3. Abdulkareem Z. Al-Musawi: Department of Cardiovascular Surgery, Basrah Health Directorate, Iraq

4. Adel Makki Abdulateef: University of Basrah and2Basrah Health Directorate, Iraq

Abstract:

Objective: To investigate acute limb ischemia (ALI) incidence, characteristics, and clinical outcomes at Basra Tertiary Hospital during the COVID-19 Pandemic. Methodology: This cross-sectional investigation included 53 COVID-19-infected patients with limb ischemia in Al-Sader teaching hospital from April 2020 to May 2022. Each patient's gender, age, smoking status, and medical history like diabetes, hypertension, hypercholesterolemia, and respiratory failure were recorded. Results: Mean age of patients was 63 ± 8 years. Out of 53 patients, 88.7% were males and most (67.9%) were 60 years old or more. 75.5 of patients were smokers, 50.9%, 39.6%, 22.6%, 28.3% had diabetes mellitus, hypertension, hypercholesterolemia and respiratory failure, respectively. There was a significant association between embolectomy, actylase anticoagulant, death and amputation. 84.6% of patients with embolectomy had amputation while 80% who took actylase anticoagulant had no amputation. Conclusion: In covid-19 related ALI, amputation was common in embolectomy patients while it was rare in patients who received actylase. Most of deceased patients had amputations.

Page(s): 548-552

DOI: DOI not available

Published: Journal: Rawal Medical Journal, Volume: 48, Issue: 3, Year: 2023

Keywords:

Acute , COVID19 , Limb ischemia , Covid19 , Basra province

References:

[1] Aasen M,Blecha M. Percutaneous .2021 .Revascularization for COVID-19 Induced Spontaneous Arterial Thrombosis. Vasc Endovascular Surg, 55 : 781-86.

[2] Santistevan JR .2017 .. Acute Limb Ischemia: An Emergency Medicine Approach. Emerg Med Clin North Am, 35 : 889-909.

[3] Yang X.,Yu Y.,Xu J.,Shu H.,Xia J.,H. Liu. J. .2020 .Clinical course and outcomes of critically ill patients with SARSCoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med, : e18.

[4] Tang N.,Li D.,Wang X.,Sun Z. .2020 .Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost, 18 : 844-7.

[5] Han H,Yang L,Liu R,Liu F,Wu KL,Li J,Liu XH,Zhu CL .2020 .Rominent changes in blood coagulation of patients with SARS-CoV-2 infection. Clin Chem Lab Med, 58 : 1116-20.

[6] Bellosta R,Luzzani L,Natalini G,Pegorer MA,Attisani L,Cossu LG .2020 .Acute limb ischemia in patients with COVID-19pneumonia. J Vasc Surg, 72 : 1864-72.

[7] Etkin Y,Conway AM,Silpe J,Qato K,Carroccio A,Manvar-Singh P .2021 .Acute Arterial Thromboembolism in Patients with COVID-19 in the New York City Area. Ann VascSurg, 70 : 290-4.

[8] Vo TD,Daoud A,Jeney A,Andacheh I,Behseresht J,Hsu J .2022 .-related Peripheral Arterial Thrombosis Treated in a Large Health Maintenance Organization. Ann Vasc Surg, 84 : 6-11.

[9] Torrealba J. I.,Osman M.,Kelso R. .2019 .Hypercoagulability predicts worse outcomes in young patients undergoing lower extremity revascularization. J Vasc Surg, 70 : 175-80.

[10] Aboyans V,Ricco JB,Bartelink MEL,Björck M,Brodmann M,Cohnert T .2018 .The Task Force for the Diagnosis and Treatment of Peripheral Arterial Diseases of the European Society of Cardiology (ESC) and of the European Society for Vascular Surgery (ESVS). Eur Heart J, 39 : 763-816.

[11] .2020 .Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. WHO reference no. , : .

[12] Kearon C,Akl EA,Ornelas J,Blaivas A,Jimenez D,Bounameaux H .2016 .. Antithrombotic Therapy for VTE Disease: CHEST Guideline and Expert Panel Report. Chest, 149 : 315-52.

[13] Li X.,Liu Y.,Wang L.,Li Z.,Ma X. .2015 .Unfractionated heparin attenuates LPS-induced IL-8 secretion via PI3K/Akt/NF-κB signaling pathway in human endothelial cells. Immunobiology, 220 : 399-405.

[14] Shastri MD,Stewart N,Horne J .2015 .In-vitro suppression of IL-6 and IL-8 release from human pulmonary epithelial cells by non-anticoagulant fraction of enoxaparin. PloS One, 10 : e0126763.

Citations

Downloads

Views